Skip to main content
SpringerLink
Log in

Human Immunodeficiency Virus (HIV)

  • Chapter
Therapy of Skin Diseases

  • 1472 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hymes KB, Cheung T, Greene JB et al (1981) Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet 19:598–600

    Article  Google Scholar 

  2. Barre-Sinoussi F, Chermann JC, Rey F et al (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for AIDS. Science 220:868–871

    Article  PubMed  CAS  Google Scholar 

  3. Gallo RC, Sarin PS, Gelmann EP et al (1983) Isolation of human T cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 220:865–867

    Article  PubMed  CAS  Google Scholar 

  4. Clavel F, Guetard D, Brun-Vezinet et al (1986) Isolation of a new human retrovirus from West African patients with AIDS. Science 233:343

    Article  PubMed  CAS  Google Scholar 

  5. UNAIDS Report on the global AIDS epidemic 2006: executive summary 1–25

    Google Scholar 

  6. UNAIDS Report on the global AIDS epidemic 2006: at risk and neglected 103–122

    Google Scholar 

  7. Li F, Zoumplis D, Matallana C et al (2006) Determinants of activity of the HIV-1 maturaton inhibitor PA-457. Virology 356:217–224

    Article  PubMed  CAS  Google Scholar 

  8. Zancanaro PC, McGirt LY, Mamelak AJ et al (2006) Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol 54:581–588

    Article  PubMed  Google Scholar 

  9. Hoffmann C, Rockstroh JK, Kamps BS (2007) HIV.NET 2007, 5th edn. Steinhäuser Verlag, Wuppertal-Beyenburg

    Google Scholar 

  10. Buchholz B, Beichert M, Marcus U et al (2006) German-Austrian recommendations for HIV therapy in pregnancy and HIV-exposed newborn-Update 2005. Eur J Med Res 11:359–376

    PubMed  Google Scholar 

  11. Bonnet F, Lewden C, May T et al (2004) Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101:317–324

    Article  PubMed  Google Scholar 

  12. Kreuter A, Brockmeyer N, Hochdorfer B et al (2005) Clinical spectrum and virologic characteristics of anal intra-epithelial neoplasia in HIV infection. J Am Acad Dermatol 52:603–608

    Article  PubMed  Google Scholar 

  13. European AIDS Clinical Society (EACS) (2005) European Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe

    Google Scholar 

  14. Salzberger B, Marcua U, Vielhaber B et al (2004) German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004). Eur J Med Res 9: 491–504

    PubMed  CAS  Google Scholar 

  15. Delta-Team (1996) A randomised double-blind controlled trial comparing combinations of zidovudine plus dianosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Commitee. Lancet 238: 283–291

    Google Scholar 

  16. The EuroGuidelines Group for HIV Resistance (2001) Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. AIDS 15:309–320

    Article  Google Scholar 

  17. Ötte M, Kaiser R, Daumer M et al (2004) Primary drug-resistance in HIV-positive patients on initiation of first-line anti-retroviral therapy in Germany. Eur J Med Res 9: 273–278

    Google Scholar 

  18. Motwani B, Khayr W (2006) Pharmacoenhancement of protease inhibitors. Am J Ther 13:57–63

    Article  PubMed  Google Scholar 

  19. Grinsztejn B, Nguyen BY, Katlama C et al (2007) Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomized controlled trial. Lancet 369:1261–1269

    Article  PubMed  CAS  Google Scholar 

  20. D'Aquila RT, Johnson VA, Welles SL et al (1995) Zidovudine resistance and HIV-1 disease progression during antiretrovi-ral therapy. Ann Intern Med 122:401–408

    PubMed  Google Scholar 

  21. Baxter JD, Mayers DL, Wentworth DN et al (2000) A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. AIDS 14:F83–F93

    Article  PubMed  CAS  Google Scholar 

  22. Cingolani A, Antinori A, Rizzo MG et al (2002) Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA). AIDS 16:369–379

    Article  PubMed  CAS  Google Scholar 

  23. DeGruttola V, Dix L, A'Aquila R et al (2000) The relationship between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther 5:43–50

    Google Scholar 

  24. Guo JJ, Jang R, Louder A, Cluxton RJ (2005) Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus. Pharmacotherapy 25:1044–1054

    Article  PubMed  Google Scholar 

  25. Goicoichea M, Best B, Capparelli E (2006) Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use. AIDS 20:2127–2128

    Article  Google Scholar 

  26. Maas B, Kerr T, Fairbairn N et al (2006) Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence. Expert Opin Drug Metab Toxicol 2:533–543

    Article  PubMed  CAS  Google Scholar 

  27. Peytavin G, Gautran C, Otoul C et al (2005) Evaluation of pharmacokinetic interaction between cetirizine and ritona-vir, an HIV-1 protease inhibitor, in healthy male volunteers. Eur J Clin Pharmacol 61:267–273

    Article  PubMed  CAS  Google Scholar 

  28. Nolan D, Mallal S (2005) Antiretroviral-therapy-associated lipoatrophy: current status and future directions. Sex Health 2:153–163

    Article  PubMed  Google Scholar 

  29. Mildvan D, Greagh T, Leitz G. The Anemia Prevalence Study Group (2007) Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin 23: 343–355

    Article  PubMed  CAS  Google Scholar 

  30. Nordstrom BL, Norman HS, Dube TJ (2007) Identification of abacavir hypersensitvity reaction in health care claims data. Pharmacoepidemiol Drug Saf 16:289–296

    Article  PubMed  CAS  Google Scholar 

  31. Stekler J, Maenza J, Stevens C et al (2006) Abacavir hyper-sensitivity reaction in primary HIV infection. AIDS 20: 1269–1274

    Article  PubMed  CAS  Google Scholar 

  32. Sax PE, Gallant JE, Klotman PE (2007) Renal safety of tenofovir disoproxil fumarate. AIDS Read 17:90–92, 99–104, C3

    PubMed  Google Scholar 

  33. Patel SM, Johnson S, Belknap SM et al (2004) Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr 35:120–125

    Article  PubMed  CAS  Google Scholar 

  34. Rihs TA, Begley K, Smith DE et al (2006) Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med 7:544–548

    Article  PubMed  CAS  Google Scholar 

  35. Molto J, Blanco A, Miranda C (2006) Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice. Br J Pharmacol 62:560–566

    Article  CAS  Google Scholar 

  36. Glesby MJ, Aberg JA, Kendall MA et al (2005) Pharmacokinetic interactions between indinavir plus ritona-vir and calcium channel blockers. Clin Pharmacol Ther 78: 143–153

    Article  PubMed  CAS  Google Scholar 

  37. Fuster D, Clotet B (2005) Review of atazanavir: a novel HIV protease inhibitor. Expert Opin Pharmacother 6:1565–1572

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergology, Ruhr University Bochum, Gudrunstraβe 56, Bochum, 44791, Germany

    Anja Potthoff

  2. Department of Dermatology, University of Cologne, Kerpener Strabe 62, Cologne, 50937, Germany

    Heinrich Rasokat & Norbert H. Brockmeyer

Authors
  1. Anja Potthoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heinrich Rasokat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norbert H. Brockmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anja Potthoff .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Köln Klinik und Poliklinik für Dermatologie und Venerologie, Kerpener Str. 62, Köln, 50924, Germany

    Thomas Krieg

  2. Dept. Dermatology, Columbia University Medical Center, 12th Floor, Herbert Irving Pavilion 161 Fort Washington Ave, New York, NY, 10032, USA

    David R. Bickers

  3. Dept. Dermatology & Cutaneous Sciences, Kyoto University Graduate School of Medicine, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Yoshiki Miyachi

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Potthoff, A., Rasokat, H., Brockmeyer, N.H. (2010). Human Immunodeficiency Virus (HIV). In: Krieg, T., Bickers, D.R., Miyachi, Y. (eds) Therapy of Skin Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78814-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78814-0_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78813-3

  • Online ISBN: 978-3-540-78814-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation